Cantau B, Guillemette G, Chicot D, Devilliers G
Mol Cell Endocrinol. 1987 May;51(1-2):59-69. doi: 10.1016/0303-7207(87)90119-5.
The binding of vasopressin, angiotensin II and prazosin (alpha 1-adrenergic antagonist) to purified heavy (GH) and (intermediate + light) (GI + L) rat liver Golgi fractions was studied. The three types of ligands showed a saturable and specific binding in Golgi fractions; the maximal specific binding of [3H]vasopressin, [3H]prazosin and [125I]Sar-N3-Phe-angiotensin II was respectively 5-10%, 20-30% and 30-40% of that detected in purified plasma membranes. The apparent binding affinities of the three ligands were the same whether determined in Golgi fractions or plasma membranes. The presence of vasopressin, alpha 1-adrenergic and angiotensin receptors in very different proportions, as compared to the amount of receptor detected in plasma membranes, in GH and GI + L Golgi fractions was not compatible with the idea that a plasma membrane impurity accounted for the detection of receptor in the purified intracellular particulate fractions. In vivo injection of [125I]Sar-N3-Phe-angiotensin II resulted in a receptor-mediated endocytosis of the iodo-angiotensin analog into the GH and GI + L Golgi fractions. The apparent molecular weight of the irreversible complex, [125I]angiotensin-receptor, was estimated in subcellular fractions using SDS-PAGE electrophoresis. This value was identical after either in vivo or in vitro labelling (MW = 63,000) and was indistinguishable from the molecular weight of the irreversible hormone receptor complex present in the plasma membranes.
研究了抗利尿激素、血管紧张素II和哌唑嗪(α1-肾上腺素能拮抗剂)与纯化的大鼠肝脏高尔基体重(GH)组分以及(中间+轻)(GI+L)组分的结合情况。这三种配体在高尔基体组分中表现出可饱和的特异性结合;[3H]抗利尿激素、[3H]哌唑嗪和[125I]Sar-N3-Phe-血管紧张素II的最大特异性结合量分别为纯化质膜中检测到量的5-10%、20-30%和30-40%。无论在高尔基体组分还是质膜中测定,这三种配体的表观结合亲和力相同。与质膜中检测到的受体量相比,GH和GI+L高尔基体组分中抗利尿激素、α1-肾上腺素能和血管紧张素受体的比例差异很大,这与质膜杂质导致在纯化的细胞内颗粒组分中检测到受体的观点不相符。体内注射[125I]Sar-N3-Phe-血管紧张素II导致碘代血管紧张素类似物通过受体介导的内吞作用进入GH和GI+L高尔基体组分。使用SDS-PAGE电泳在亚细胞组分中估计不可逆复合物[125I]血管紧张素-受体的表观分子量。体内或体外标记后该值相同(分子量=63,000),且与质膜中存在的不可逆激素受体复合物的分子量无法区分。